Top

Health Economics Review

Published in:

Open Access 01-12-2024 | Review

End-of-life expenditure on health care for the older population: a scoping review

Authors: Ewa Kocot, Azzurra Ferrero, Shibu Shrestha, Katarzyna Dubas-Jakóbczyk

Published in: Health Economics Review | Issue 1/2024

Abstract

Background

The existing evidence shows that the pattern of health expenditure differs considerably between people at the end-of-life and people in other periods of their lives. The awareness of these differences, combined with a detailed analysis of future mortality rates is one of the key pieces of information needed for health spending prognoses. The general objective of this review was to identify and map the existing empirical evidence on end-of-life expenditure related to health care for the older population.

Methods

To achieve the objective of the study a systematic scoping review was performed. There were 61 studies included in the analysis. The project has been registered through the Open Science Framework.

Results

The included studies cover different kinds of expenditure in terms of payers, providers and types of services, although most of them include analyses of hospital spending and nearly 60% of analyses were conducted for insurance expenditure. The studies provide very different results, which are difficult to compare. However, all of the studies analyzing expenditure by survivorship status indicate that expenditure on decedents is higher than on survivors. Many studies indicate a strong relationship between health expenditure and proximity to death and indicate that proximity to death is a more important determinant of health expenditure than age per se. Drawing conclusions on the relationship between end-of-life expenditure and socio-economic status would be possible only by placing the analysis in a broader context, including the rules of a health system’s organization and financing. This review showed that a lot of studies are focused on limited types of care, settings, and payers, showing only a partial picture of health and social care systems in the context of end-of-life expenditure for the older population.

Conclusion

The results of studies on end-of-life expenditure for the older population conducted so far are largely inconsistent. The review showed a great variety of problems appearing in the area of end-of-life expenditure analysis, related to methodology, data availability, and the comparability of results. Further research is needed to improve the methods of analyses, as well as to develop some analysis standards to enhance research quality and comparability.

Available only for authorised users

Gastaldi-Ménager C, Geoffard PY, de Lagasnerie G. Medical spending in France: concentration, persistence and evolution before death. Fisc Stud. 2016;37(3–4):499–526. https://doi.org/10.1111/j.1475-5890.2016.12107.CrossRef

Duncan I, Ahmed T, Dove H, Maxwell TL. Medicare Cost at end of life. Am J Hosp Palliat Care. 2019;36(8):705–10. https://doi.org/10.1177/1049909119836204.CrossRefPubMedPubMedCentral

Hoover DR, Crystal S, Kumar R, Sambamoorthi U, Cantor JC. Medical expenditures during the last year of life: findings from the 1992–1996 medicare current beneficiary survey. Health Serv Res. 2002;37(6):1625–42. https://doi.org/10.1111/1475-6773.01113.CrossRefPubMedPubMedCentral

Hogan C, Lunney J, Gabel J, Lynn J. Medicare beneficiaries’ costs of care in the last year of life. Health Aff. 2001;20(4):188–95. https://doi.org/10.1377/hlthaff.20.4.188.CrossRef

Global Health Data Exchange, Tool GBDR. https://ghdx.healthdata.org/gbd-results-tool. Accessed 15 September 2022.

UN Population Division Data Portal., https://population.un.org/dataportal/home. Accessed 20 September 2022.

Normand C, May P, Johnston B, Cylus J. Health and Social Care Near the End of Life. Can policies reduce costs and improve outcomes? WHO Regional Office for Europe; 2021.

European Commission. : The 2021 Ageing Report. Economic & Budgetary projections for the EU Member States (2019 – 2017). Institutional Paper 148. (2021).

Melberg HO, Sørensen J, Melberg HO, Sørensen J. How does end of life costs and increases in life expectancy affect projections of future hospital spending? (2013).

10.

Blakely T, Atkinson J, Kvizhinadze G, Nghiem N, Mcleod H, Wilson N. Health system costs by sex, age and proximity to death, and implications for estimation of future expenditure. J New Zeal Med Assoc. 2014;127(1393):12–25.

11.

Yu CW, Alavinia SM, Alter DA. Impact of socioeconomic status on end-of-life costs: a systematic review and meta-analysis. (2020). https://doi.org/10.1186/s12904-020-0538-y.

12.

Rome RB, Luminais HH, Bourgeois DA, Blais CM. The role of Palliative Care at the end of life. Ochsner J. 2011;11(4):348352.

13.

Mota-Romero E, Esteban-Burgos AA, Puente-Fernández D, García-Caro MP, Hueso-Montoro C, Herrero-Hahn RM, Montoya-Juárez R. NUrsing homes End of Life care program (NUHELP): developing a complex intervention. BMC Palliat Care. 2021;20(1):98. https://doi.org/10.1186/S12904-021-00788-1/TABLES/4.CrossRefPubMedPubMedCentral

14.

Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Undefined. 2005;8(1):19–32. https://doi.org/10.1080/1364557032000119616.CrossRef

15.

Levac D, Colquhoun H, O’Brien KK. Scoping studies: advancing the methodology. Implement Sci. 2010;5(1). https://doi.org/10.1186/1748-5908-5-69.

16.

Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, Moher D, Peters MDJ, Horsley T, Weeks L, Hempel S, Akl EA, Chang C, McGowan J, Stewart L, Hartling L, Aldcroft A, Wilson MG, Garritty C, Lewin S, Godfrey CM, MacDonald MT, Langlois EV, Soares-Weiser K, Moriarty J, Clifford T, Tunçalp Ö, Straus SE. PRISMA Extension for scoping reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018;169(7):467–73. https://doi.org/10.7326/M18-0850.CrossRefPubMed

17.

Open Science Framework project registration., https://osf.io/86wkq?mode=&revisionId=&view_only=. Accessed 11 December 2022.

18.

Higginson IJ, Yi D, Johnston BM, Ryan K, McQuillan R, Selman L, Pantilat SZ, Daveson BA, Morrison RS, Normand C. Associations between informal care costs, care quality, carer rewards, burden and subsequent grief: the international, access, rights and empowerment mortality follow-back study of the last 3 months of life (IARE I study). BMC Med. 2020;18(1). https://doi.org/10.1186/s12916-020-01768-7.

19.

Yi D, Johnston BM, Ryan K, Daveson BA, Meier DE, Smith M, McQuillan R, Selman L, Pantilat SZ, Normand C, Morrison RS, Higginson IJ. Drivers of care costs and quality in the last 3 months of life among older people receiving palliative care: a multinational mortality follow-back survey across England, Ireland and the United States. Palliat Med. 2020;34(4):513–23. https://doi.org/10.1177/0269216319896745.CrossRefPubMed

20.

Brameld KJ, Holman CD, Bass AJ, Codde JP, Rouse IL. Hospitalisation of the elderly during the last year of life: an application of record linkage in western Australia 1985–1994. J Epidemiol Community Health. 1998;52(11):740–4. https://doi.org/10.1136/jech.52.11.740.CrossRefPubMedPubMedCentral

21.

Kardamanidis K, Lim K, Da Cunha C, Taylor LK, Jorm LR. Hospital costs of older people in New South Wales in the last year of life. Med J Aust. 2007;187(7):383–6. https://doi.org/10.5694/J.1326-5377.2007.TB01306.X.CrossRefPubMed

22.

Gielen B, Remacle A, Mertens R. Patterns of health care use and expenditure during the last 6 months of life in Belgium: differences between age categories in cancer and non-cancer patients. Health Policy. 2010;97(1):53–61. https://doi.org/10.1016/j.healthpol.2010.03.002.CrossRefPubMed

23.

Demers M. Age differences in the rates and costs of medical procedures and hospitalization during the last year of life. Can J Aging. 1998;17(2):186–96. https://doi.org/10.1017/S0714980800009259.CrossRef

24.

Guerin E, Batista R, Hsu AT, Gratton V, Chalifoux M, Prud’Homme D, Tanuseputro P. Does end-of-Life Care Differ for anglophones and francophones? A retrospective cohort study of decedents in Ontario, Canada. J Palliat Med. 2019;22(3):274–81. https://doi.org/10.1089/jpm.2018.0233.CrossRefPubMed

25.

Hollander MJ. Costs of end-of-life care: findings from the province of Saskatchewan. Healthc Q. 2009;12(3):50–8. https://doi.org/10.12927/hcq.2013.20878.CrossRefPubMed

26.

McGrail K, Green B, Barer ML, Evans RG, Hertzman C, Normand C. Age, costs of acute and long-term care and proximity to death: evidence for 1987-88 and 1994-95 in British Columbia. Age Ageing. 2000;29(3):249–53. https://doi.org/10.1093/ageing/29.3.249.CrossRefPubMed

27.

Tanuseputro P, Wodchis WP, Fowler R, Walker P, Bai YQ, Bronskill SE, Manuel D. The health care cost of dying: a population-based retrospective cohort study of the last year of life in Ontario, Canada. PLoS ONE. 2015;10(3):e0121759–9. https://doi.org/10.1371/journal.pone.0121759.CrossRefPubMedPubMedCentral

28.

Zhu B, Li F, Wang C, Wang L, He Z, Zhang X, Song P, Ding L, Jin C. Tracking hospital costs in the last year of life - the Shanghai experience. Biosci Trends. 2018;12(1):79–86. https://doi.org/10.5582/bst.2017.01245.CrossRefPubMed

29.

Hansen AV, Mortensen LH, Trompet S, Westendorp R. Health care expenditure in the last five years of life is driven by morbidity, not age: a national study of spending trajectories in Danish decedents over age 65. PLoS ONE. 2020;15(12):1–11. https://doi.org/10.1371/journal.pone.0244061.CrossRef

30.

Häkkinen U, Martikainen P, Noro A, Nihtilä E, Peltola M. Aging, health expenditure, proximity to death, and income in Finland. Heal Econ Policy Law. 2008;3(2):165–95. https://doi.org/10.1017/S174413310800443X.CrossRef

31.

Bell-Aldeghi R, Sirven N, Le Guern M, Sevilla-Dedieu C. One last effort. Are high out-of-pocket payments at the end of life a fatality? Eur. J Heal Econ. 2022;23(5):879–91. https://doi.org/10.1007/s10198-021-01401-1.CrossRef

32.

Koczor-Keul M. Patterns of active inpatient care expenditures for the Hungarian elderly in the last year of life. Bull Transilv Univ Brasov Econ Sci Ser V. 2017;10(2):223–34.

33.

Alipour V, Pourreza A, Kosheshi M, Heydari H, Emamgholipour Sefiddashti S. Hospital expenditure at the end-of-Life: a time-to-death Approach. Int J Heal Policy Manag. 2022;11(2):138–44. https://doi.org/10.34172/ijhpm.2020.88.CrossRef

34.

Moore PV, Bennett K, Normand C. Counting the time lived, the time left or illness? Age, proximity to death, morbidity and prescribing expenditures. Soc Sci Med. 2017;184:1–14. https://doi.org/10.1016/j.socscimed.2017.04.038.CrossRefPubMed

35.

Shmueli A, Messika D, Zmora I, Oberman B. Health care costs during the last 12 months of life in Israel: estimation and implications for risk-adjustment. Int J Health Care Finance Econ. 2010;10(3):257–73. https://doi.org/10.1007/s10754-010-9080-4.CrossRefPubMed

36.

Hashimoto H, Horiguchi H, Matsuda S. Micro data analysis of medical and long-term care utilization among the elderly in Japan. Int J Environ Res Public Health. 2010;7(8):3022–37. https://doi.org/10.3390/ijerph7083022.CrossRefPubMedPubMedCentral

37.

Teraoka E, Kunisawa S, Imanaka Y. Trajectories of end-of-life medical and long-term care expenditures for older adults in Japan: retrospective longitudinal study using a large-scale linked database of medical and long-term care claims. BMC Geriatr. 2021;21(1):403. https://doi.org/10.1186/s12877-021-02215-9.CrossRefPubMedPubMedCentral

38.

Boo S, Lee J, Oh H. Cost of care and pattern of medical care use in the last year of life among long-term care insurance beneficiaries in South Korea: using national claims data. Int J Environ Res Public Health. 2020;17(23):1–10. https://doi.org/10.3390/ijerph17239078.CrossRef

39.

Hyun K-R, Kang S, Lee S, Heal. Econ (United Kingdom). 2016;25(10):1239–51. https://doi.org/10.1002/hec.3209.CrossRef

40.

Van Vliet RCJA, Lamers LM. The high costs of death: should Health plans get higher payments when Members die? Med. Care. 1998;36(10):1451–60. https://doi.org/10.1097/00005650-199810000-00003.CrossRef

41.

Blakely T, Atkinson J, Kvizhinadze G, Nghiem N, McLeod H, Davies A, Wilson N. Updated New Zealand health system cost estimates from health events by sex, age and proximity to death: further improvements in the age of ‘big data.’ N. Z Med J. 2015;128(1422):13–23.

42.

Scott OW, Gott M, Edlin R, Moyes SA, Muru-Lanning M, Kerse N. Correction to: costs of inpatient hospitalisations in the last year of life in older New zealanders: a cohort study. BMC Geriatr. 2021;21(514):135. https://doi.org/10.1186/s12877-021-02735-4.CrossRef

43.

Melberg HO, Godager G, Gregersen FA. Hospital expenses towards the end of life. Tidsskr nor Legeforen. 2013;133(8):841–4. https://doi.org/10.4045/tidsskr.12.0802.CrossRef

44.

Ranchod S, Abraham M, Bloch J. An actuarial perspective on healthcare expenditure in the last year of life. South Afr Actuar J. 2015;15(1):31–49. https://doi.org/10.4314/saaj.v15i1.2.CrossRef

45.

Hanratty B, Burström B, Walander A, Whitehead M. Inequality in the face of death? Public expenditure on health care for different socioeconomic groups in the last year of life. J Heal Serv Res Policy. 2007;12(2):90–4. https://doi.org/10.1258/135581907780279585.CrossRef

46.

Felder S. Health care expenditure towards the end of life. Cardiovasc. drugs Ther. 15(4), 345–347 (2001). https://doi.org/https://doi.org10.1023/a:1012714800014.

47.

Felder S, Meier M, Schmitt H. Health care expenditure in the last months of life. J Health Econ. 2000;19(5):679–95. https://doi.org/10.1016/s0167-6296(00)00039-4.CrossRefPubMed

48.

Outreville JF. The Ageing Population and the future of Healthcare Plans. Geneva Pap Risk Insur. 2001;26(1):126–31. https://doi.org/10.1111/1468-0440.00100.CrossRef

49.

Panczak R, Luta X, Maessen M, Stuck AE, Berlin C, Schmidlin K, Reich O, von Wyl V, Goodman DC, Egger M, Zwahlen M, Clough-Gorr KM. Regional Variation of cost of care in the last 12 months of life in Switzerland. Med Care. 2017;55(2):155–63. https://doi.org/10.1097/mlr.0000000000000634.CrossRefPubMed

50.

von Wyl V, Telser H, Weber A, Fischer B, Beck K. BMJ Support Palliat Care. 2018;8(3):325–34. https://doi.org/10.1136/bmjspcare-2014-000784. Cost trajectories from the final life year reveal intensity of end-of-life care and can help to guide palliative care interventions.

51.

Zweifel P, Felder S, Meiers M. Ageing of population and health care expenditure: a red herring? Health Econ. 1999;8(6):485–96. https://doi.org/10.1002/(SICI)1099-1050(199909)8:6<485::AID-HEC461>3.0.CO;2-4.CrossRefPubMed

52.

Liu C-N, Yang MC. National Health Insurance expenditure for adult beneficiaries in Taiwan in their last year of life. J Formos Med Asso. 2002;101(8):552–9.

53.

Geue C, Lorgelly P, Lewsey J, Hart C, Briggs A. Hospital expenditure at the end-of-life: what are the impacts of health status and health risks? PLoS ONE. 2015;10(3). https://doi.org/10.1371/journal.pone.0119035. e0119035.

54.

Hazra NC, Rudisill C, Gulliford MC. Determinants of health care costs in the senior elderly: age, comorbidity, impairment, or proximity to death? Eur J Health Econ. 2018;19(6):831–42. https://doi.org/10.1007/s10198-017-0926-2.CrossRefPubMed

55.

Jayatunga W, Lewer D, Shand J, Sheringham J, Morris S, George J. Health and social care costs at the end of life: a matched analysis of linked patient records in East London. Age Ageing. 2019;49(1):82–7. https://doi.org/10.1093/ageing/afz137.CrossRefPubMed

56.

Luta X, Diernberger K, Bowden J, Droney J, Howdon D, Schmidlin K, Rodwin V, Hall P, Marti J. Healthcare trajectories and costs in the last year of life: a retrospective primary care and hospital analysis. BMJ Support Palliat Care. 2020;1–9. https://doi.org/10.1136/bmjspcare-2020-002630.

57.

Bird CE, Shugarman LR, Lynn J. Age and gender differences in health care utilization and spending for medicare beneficiaries in their last years of life. J Palliat Med. 2002;5(5):705–12. https://doi.org/10.1089/109662102320880525.CrossRefPubMed

58.

Davis MA, Nallamothu BK, Banerjee M, Bynum JPW. Patterns of Healthcare spending in the Last Year of Life. Health Aff (Millwood). 2016;35(7):1316–23. https://doi.org/10.1377/hlthaff.2015.1419.Patterns.CrossRefPubMed

59.

Gozalo P, Plotzke M, Mor V, Miller SC, Teno JM. Changes in Medicare costs with the growth of hospice care in nursing homes. N Engl J Med. 2015;372(19):1823–31. https://doi.org/10.1056/NEJMSA1408705.CrossRefPubMedPubMedCentral

60.

Hanchate A, Kronman AC, Young-Xu Y, Ash AS, Emanuel E. Racial and ethnic differences in end-of-life costs: why do minorities cost more than whites? Arch Intern Med. 2009;169(5):493–501. https://doi.org/10.1001/ARCHINTERNMED.2008.616.CrossRefPubMedPubMedCentral

61.

Holland SK, Evered SR, Center BA. Long-term care benefits may reduce end-of-life medical care costs. Popul Health Manag. 2014;17(6):332–9. https://doi.org/10.1089/pop.2013.0116.CrossRefPubMedPubMedCentral

62.

Kelley A. The burden of healthcare costs in the last five years of life. J Pain Symptom Manage. 2016;51(2):352–3. https://doi.org/10.1016/j.jpainsymman.2015.12.199.CrossRef

63.

Khandelwal N, White L, Curtis JR, Coe NB. Health Insurance and out-of-Pocket costs in the Last Year of Life among decedents utilizing the ICU. Crit. Care Med. 2019;47(6):749–56. https://doi.org/10.1097/CCM.0000000000003723.CrossRef

64.

Lubitz J, Prihoda R. The use and costs of Medicare services in the last 2 years of life. Health Care Financ Rev. 1984;5(3):117–31.PubMedPubMedCentral

65.

Lubitz JD, Riley GF. Trends in Medicare payments in the last year of life. N Engl J Med. 1993;328(15):1092–6. https://doi.org/10.1056/NEJM199304153281506.CrossRefPubMed

66.

McGarry K, Schoeni RF. Widow(er) poverty and out-of-pocket medical expenditures near the end of life. J Gerontol B Psychol Sci Soc Sci. 2005;60(3):160–8. https://doi.org/10.1093/geronb/60.3.s160.CrossRef

67.

Riley G, Lubitz J. Long-term trends in Medicare payments in the Last Year of Life. Heal Serv Res. 2010;45(2):565–76. https://doi.org/10.1111/j.1475-6773.2010.01082.x.CrossRef

68.

Scitovsky AA. Medical care in the last twelve months of life: the relation between age, functional status, and medical care expenditures. Milbank Q. 1988;66(4):640–60. https://doi.org/10.2307/3349934.CrossRefPubMed

69.

Shugarman LR, Campbell DE, Bird CE, Gabel J, Louis TA, Lynn J. Differences in medicare expenditures during the last 3 years of life. J Gen Intern Med. 2004;19(2):127–35. https://doi.org/10.1111/j.1525-1497.2004.30223.x.CrossRefPubMedPubMedCentral

70.

Sullivan SS, Li J, Wu Y-WB, Hewner S. Complexity of chronic conditions’ impact on end-of-life expense trajectories of Medicare decedents. J Nurs Adm. 2017;47(11):545–50. https://doi.org/10.1097/NNA.0000000000000541.CrossRefPubMedPubMedCentral

71.

Yang Z, Norton EC, Stearns SC. Longevity and health care expenditures: the real reasons older people spend more. J Gerontol B Psychol Sci Soc Sci. 2003;58(1):2–S10. https://doi.org/10.1093/geronb/59.3.s197-a.CrossRef

72.

Zuckerman RB, Stearns SC, Sheingold SH. Hospice Use, hospitalization, and Medicare Spending at the end of life. J Gerontol B Psychol Sci Soc Sci. 2016;71(3):569–80. https://doi.org/10.1093/geronb/gbv109.CrossRefPubMed

73.

Miller SC, Intrator O, Gozalo P, Roy J, Barber J, Mor V. Government expenditures at the end of life for short- and long-stay nursing home residents: differences by hospice enrollment status. J Am Geriatr Soc. 2004;52(8):1284–92. https://doi.org/10.1111/j.1532-5415.2004.52357.x.CrossRefPubMed

74.

Lipscombe LL, Hux JE. Trends in Diabetes prevalence, incidence, and mortality in Ontario, Canada 1995–2005: a population-based study. Lancet (London England). 2007;369(9563):750–6. https://doi.org/10.1016/S0140-6736(07)60361-4.CrossRefPubMed

75.

Corrada E, Ferrante G, Mazzali C, Barbieri P, Merlino L, Merlini P, Presbitero P. Eleven-year trends in gender differences of treatments and mortality in ST-elevation acute myocardial infarction in northern Italy, 2000 to 2010. Am J Cardiol. 2014;114(3):336–41. https://doi.org/10.1016/J.AMJCARD.2014.05.007.CrossRefPubMed

76.

Mazzali C, Duca P. Use of administrative data in healthcare research. Intern Emerg Med. 2015;10(4):517–24. https://doi.org/10.1007/s11739-015-1213-9.CrossRefPubMed

77.

World Health Organization. Validity and comparability of out-of-pocket health expenditure from household surveys: a review of the literature and current survey instruments. World Health Organization; 2011.

78.

Breyer F, Lorenz N. The red herring after 20 years: ageing and health care expenditures. Eur J Heal Econ. 2021;22(5):661–7. https://doi.org/10.1007/s10198-020-01203-x.CrossRef

79.

Stearns SC, Norton EC. Time to include time to death? The future of health care expenditure predictions. Health Econ. 2004;13(4):315–27. https://doi.org/10.1002/HEC.831.CrossRefPubMed

80.

Polder JJ, Barendregt JJ, van Oers H. Health care costs in the last year of life–the Dutch experience. Soc Sci Med. 2006;63(7):1720–31. https://doi.org/10.1016/J.SOCSCIMED.2006.04.018.CrossRefPubMed

81.

Bjørner TB, Arnberg S. Terminal costs, improved life expectancy and future public health expenditure. Int J Health Care Finance Econ. 2012;12(2):129–43. https://doi.org/10.1007/S10754-012-9106-1.CrossRefPubMed

82.

Scitovsky AA. The high cost of dying: what do the data show? 1984. Milbank Q. 2005;83(4):825–41. https://doi.org/10.1111/J.1468-0009.2005.00402.X.CrossRefPubMedPubMedCentral

83.

Cardona-Morrell M, Kim JCH, Turner RM, Anstey M, Mitchell IA, Hillman K. Non-beneficial treatments in hospital at the end of life: a systematic review on extent of the problem. Int J Qual Heal care J Int Soc Qual Heal Care. 2016;28(4):456–69. https://doi.org/10.1093/INTQHC/MZW060.CrossRef

Title: End-of-life expenditure on health care for the older population: a scoping review
Authors: Ewa Kocot
Azzurra Ferrero
Shibu Shrestha
Katarzyna Dubas-Jakóbczyk
Publication date: 01-12-2024
Publisher: Springer Berlin Heidelberg
Published in: Health Economics Review / Issue 1/2024
Electronic ISSN: 2191-1991
DOI: https://doi.org/10.1186/s13561-024-00493-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

End-of-life expenditure on health care for the older population: a scoping review

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2024

Insurance barriers and inequalities in health care access: evidence from dual practice

Budget impact analysis of continuous glucose monitoring in individuals with type 2 diabetes on insulin treatment in England

Examining confidential wholesale margin estimates in European countries for the price negotiation of patented drugs in Germany: a statistical model

Predicting healthcare expenditure based on Adjusted Morbidity Groups to implement a needs-based capitation financing system

Impact of 2009 American Recovery and Reinvestment Act (ARRA) health center investments on disadvantaged neighborhoods after recession

An analysis of the trend towards universal health coverage and access to healthcare in Morocco